Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2025-06-03 (cashcow.nl)
Breakthrough Pharming; Where is the upper limit? -
- The Pharming Group NV (Pharm) share ended at 1.02 euros after an increase of 3.5%, and thus broke the 1.00 point limit. Chart-commentary
Read more
2025-03-14 (cashcow.nl)
Upper limit Pharming at 0.96 euros -
- Pharming Group NV (Pharm) closed at 0.84 euros after rising 16.5%. The last time the share rose just as much on November 26, 2020, when the
Read more
2024-12-31 (iex.nl)
Morgan Stanley bigger in Pharming
Morgan Stanley has announced a larger stake in Pharming Group. This emerged from a notification in the context of the Financial Supervision Act, dated December 27, 2024.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-12-19 (iex.nl)
RBC significantly increases Pharming price target
RBC increased the price target for Pharming Group from 1.60 to 2.15 euros on Thursday and maintained the Outperform recommendation. This was evident from an analyst report from RBC.
Read more
2024-09-26 (iex.nl)
Micron effect on the stock market? AEX is heading for a nice opening, chip shares in Asia are flying
Opening indication AEX: +1.2%, after stock market celebration in Asia. Chip stocks in particular were not up to par, after Micron figures and SK Hynix news. And furthermore: Pharming, bitcoin and Switzerland.
Read more
2024-09-26 (iex.nl)
Micron effect on the stock market? AEX is heading for a nice opening, chip shares in Asia are flying
Opening indication AEX: +1.2%, after stock market celebration in Asia. Chip stocks in particular were not up to par, after Micron figures and SK Hynix news. And furthermore: Pharming, bitcoin and Switzerland.
Read more
2024-09-06 (iex.nl)
Pharming Turbo Long 0,26
The price of Pharming Turbo Long 0.26 (Turbo, PSE) with news items, columns, agenda, forum, technical analysis, fundamental analysis, options, turbos, speeders, sprinters and advice
Read more
2024-05-10 (deaandeelhouder.nl)
Stock market view: RBC lowers Pharming price target
RBC lowered the price target for Pharming from 1.85 to 1.65 euros on Friday with a repeat of the buy recommendation. This was evident from an analyst report from RBC. “The biggest risk to our buy recommendation is a major setback for Joenja, commercially or from a regulatory perspective,” RBC said.
Read more